Kabra Drugs Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 271637, "name": "Kabra Drugs", "stock_name": "Kabra Drugs", "full_name": "Kabra Drugs Ltd", "name_url": "stocks-analysis/kabra-drugs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "22.22", "chg": -0.64, "chgp": "-2.8%", "dir": -1, "prev_price": "22.86", "mcapval": "52.68 Cr", "mcap": "Micro Cap", "scripcode": 524322, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE323K01017", "curr_date": "Jul 08, 02:10 PM", "curr_time": "14:11 PM", "last_traded_at": "Jul 08, 02:10 PM IST", "bse_nse_vol": "45.45 k", "exc_status": "Active", "traded_date": "Jul 08, 2026", "traded_date_str": "2026 07 08", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kabra-drugs-271637-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4093531", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KabraDrugsLtd_mojoScore_4093531.png", "date": "2026-07-08 10:10:04", "description": "Kabra Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with the most up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Kabra Drugs Ltd Downgraded to Sell Amid Mixed Financials and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-downgraded-to-sell-amid-mixed-financials-and-bearish-technicals-4068381", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_mojoScore_4068381.png", "date": "2026-06-23 08:32:04", "description": "Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 22 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, valuation concerns, and mixed financial trends despite recent positive quarterly results." }, { "title": "Kabra Drugs Gains 1.06%: 2 Key Technical Signals Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/kabra-drugs-gains-106-2-key-technical-signals-shape-weekly-trend-4066231", "imagepath": "", "date": "2026-06-21 11:00:52", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Jun:</strong> Stock surges 13.50% to Rs.26.82 on upgrade to Hold</p>\n <p><strong>16 Jun:</strong> MarketsMOJO upgrades Kabra Drugs Ltd to Hold rating</p>\n <p><strong>17 Jun:</strong> Death Cross forms signalling potential bearish trend</p>\n <p><strong>19 Jun:</strong> Week closes at Rs.23.88, down 3.20% on final day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.23.63</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.23.88<..." }, { "title": "Kabra Drugs Ltd Forms Death Cross Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/kabra-drugs-ltd-forms-death-cross-signalling-potential-bearish-trend-4059719", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_dealthcross_4059719.png", "date": "2026-06-17 18:00:17", "description": "Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock’s medium to long-term momentum and investor sentiment." }, { "title": "Kabra Drugs Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financials-4055384", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_mojoScore_4055384.png", "date": "2026-06-16 08:32:56", "description": "Kabra Drugs Ltd has seen its investment rating upgraded from Sell to Hold as of 15 June 2026, reflecting a notable improvement in its technical indicators and financial results. The pharmaceutical micro-cap’s Mojo Score rose to 58.0, signalling a more balanced outlook amid recent positive trends in sales growth, profitability, and market momentum." }, { "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4035838", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_mojoScore_4035838.png", "date": "2026-06-04 10:10:48", "description": "Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "When is the next results date for Kabra Drugs Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-kabra-drugs-ltd-4007511", "imagepath": "", "date": "2026-05-22 23:21:30", "description": "The next results date for Kabra Drugs Ltd is scheduled for 29 May 2026...." } ], "total": 60, "sid": "271637", "stock_news_url": "https://www.marketsmojo.com/news/kabra-drugs-271637" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "26-Jun-2026", "details": "Closure of Trading Window", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "14-Jun-2026", "details": "Press Release on Letter of Intent from Goverment of Chhattisgarh for Rs.200 Crore Pharmaceutical Manufacturing Project", "source": "BSE" }, { "caption": "Revised Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of Rs. 200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma Park", "datetime": "13-Jun-2026", "details": "Revised due to typo error in date", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Jun: Stock surges 13.50% to Rs.26.82 on upgrade to Hold

16 Jun: MarketsMOJO upgrades Kabra Drugs Ltd to Hold rating

17 Jun: Death Cross forms signalling potential bearish trend

19 Jun: Week closes at Rs.23.88, down 3.20% on final day

Read full news article

Kabra Drugs Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-06-17 18:00:17

Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock’s medium to long-term momentum and investor sentiment.

Read full news article

Kabra Drugs Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials

2026-06-16 08:32:56

Kabra Drugs Ltd has seen its investment rating upgraded from Sell to Hold as of 15 June 2026, reflecting a notable improvement in its technical indicators and financial results. The pharmaceutical micro-cap’s Mojo Score rose to 58.0, signalling a more balanced outlook amid recent positive trends in sales growth, profitability, and market momentum.

Read full news article

Kabra Drugs Ltd is Rated Sell by MarketsMOJO

2026-06-04 10:10:48

Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

When is the next results date for Kabra Drugs Ltd?

2026-05-22 23:21:30

The next results date for Kabra Drugs Ltd is scheduled for 29 May 2026....

Read full news article